Login
Support
Search
Search
Search
ISPE
Upcoming Events
On Demand
×
The Global Pharmaceutical Manufacturing Leadership Forum: Fall 2020 Meeting
Search
Search
Search
Advanced Filters
Welcome and Opening
Date
November 1, 2020
Speakers
Paul Heiden
Senior VP Corporate, Quality
,
Bayer AG
Lou Schmukler
EVP & President, Global Product Development & Supply
,
Bristol-Meyers Squibb
Introduction & Presentation by FDA
Date
November 1, 2020
Session Leader
Frances M. Zipp
President & CEO
,
Lachman Consultant Services
Speaker
Stephen M. Hahn
,
MD
Commissioner
,
FDA
Learning from COVID Panel
Date
November 1, 2020
Session Leader
Lou Schmukler
EVP & President, Global Product Development & Supply
,
Bristol-Meyers Squibb
Panelists
Brian Hasselbalch
Deputy Director, Office of Policy or Pharmaceutical Quality (OPPQ)
,
FDA/CDER/OPQ
Noreen Gleason
Director of Operations
,
Bristol Myers Squib
Mike McDermott
President
,
Pfizer Global Supply
Remo Colarusso
Vice President, Janssen Supply Chain
,
Janssen Supply Chain, LLC at Johnson & Johnson
Theresa Rodó
Executive Vice President, Head of Global Healthcare Operations
,
Merck KGaA
Joey Gouws
,
PhD
Team Lead, Inspection Services, Prequalification Team
,
World Health Organization
Workforce of the Future
Date
November 1, 2020
Session Leader
Frances M. Zipp
President & CEO
,
Lachman Consultant Services
Speakers
Katy George
Senior Partner
,
McKinsey & Company, Inc
Pam Cheng
Executive VP of Global Operations & IT, Chief Sustainability Officer
,
AstraZeneca
Advancing Pharmaceutical Quality: Power of Data and Analytics
Date
November 1, 2020
Session Leader
Joseph Famulare
Conference Chair, VP Global Compliance & External Collaboration
,
Genentech, A Member of the Roche Group
Speakers
Tami J. Frederick
Senior Director, Corporate Quality Systems & Cultural Excellence
,
Perrigo
Jennifer Maguire
,
PhD
Director of the Office of Quality Surveillance
,
CDER/FDA
David Churchward
Head of Operations Quality Compliance and External Affairs
,
AstraZeneca
Supply Chain Impact From CMO Viewpoint
Date
November 1, 2020
Session Leader
Jim Breen
VP Project Lead, Biologics Expansion
,
Janssen Pharmaceuticals
Speakers
Michel Lagarde
Executive Vice President
,
Thermo Fisher Scientific
John Chiminski
Chair & CEO
,
Catalent Pharma Solutions
Closing and Next Steps
Date
November 1, 2020
Speaker
Lou Schmukler
EVP & President, Global Product Development & Supply
,
Bristol-Meyers Squibb
×
Evaluation